AirSculpt Technologies In...

5.10
-0.19 (-3.59%)
At close: Jan 22, 2025, 3:59 PM
5.07
-0.59%
After-hours Jan 22, 2025, 04:00 PM EST

Company Description

AirSculpt Technologies, Inc., together with its subsidiaries, focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States.

It offers custom body contouring using its AirSculpt procedure that removes unwanted fat in a minimally invasive procedure.

The company provides fat removal procedures across treatment areas; and fat transfer procedures that use the patient's own fat cells to enhance the breasts, buttocks, hips, or other areas.

Its body contouring procedures also include the Power BBL, a Brazilian butt lift procedure; the Up a Cup, a breast enhancement procedure; and the Hip Flip, an hourglass contouring procedure.

As of March 10, 2022, it operated 19 centers across 15 states.

AirSculpt Technologies, Inc. was founded in 2012 and is headquartered in Miami Beach, Florida.

AirSculpt Technologies Inc.
AirSculpt Technologies Inc. logo
Country United States
IPO Date Oct 29, 2021
Industry Medical - Care Facilities
Sector Healthcare
Employees 346
CEO Yogesh Jashnani

Contact Details

Address:
400 Alton Road
Miami Beach, Florida
United States
Website https://www.elitebodysculpture.com

Stock Details

Ticker Symbol AIRS
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001870940
CUSIP Number 009496100
ISIN Number US0094961002
Employer ID 87-1471855
SIC Code 8011

Key Executives

Name Position
Yogesh Jashnani Chief Executive Officer & Director
Dennis Dean CPA Chief Financial Officer
Stephanie Evans Greene Chief Marketing Officer
Dr. Aaron J. Rollins M.D. Founder & Executive Chairman
Philip Bodie Chief Accounting Officer

Latest SEC Filings

Date Type Title
Jan 13, 2025 8-K Current Report
Jan 08, 2025 4 Filing
Jan 08, 2025 3 Filing
Dec 26, 2024 8-K Current Report
Dec 17, 2024 8-K Current Report
Nov 15, 2024 4 Filing
Nov 15, 2024 4 Filing
Nov 15, 2024 3 Filing
Nov 08, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Nov 08, 2024 10-Q Quarterly Report